Institute of Advanced Diagnostic and Clinical Medicine, Zhongshan City People's Hospital, Zhongshan, China.
Department of Anesthesiology, Zhongshan City People's Hospital, Zhongshan, China.
Gut Microbes. 2023 Jan-Dec;15(1):2233146. doi: 10.1080/19490976.2023.2233146.
The efficacy of COVID-19 vaccines varies between individuals and populations, and the reasons for this are still not fully understood. Recent clinical studies and animal models have indicated that the gut microbiota may influence the immunogenicity of the vaccine and, thus, its effectiveness. This suggests that there is a bidirectional relationship between the gut microbiota and the COVID-19 vaccine, with the varying components of the microbiota either enhancing or reducing the vaccine's efficacy. To put an end to the spread of the COVID-19 pandemic, the necessity of vaccines that create powerful and long-term immunity is now more important than ever, and understanding the role of the gut microbiota in this process is essential. Conversely, COVID-19 vaccines also have a significant effect on the gut microbiota, decreasing its total number of organisms and the variety of species present. In this Review, we analyze the evidence that suggesting an interaction between the gut microbiota and COVID-19 vaccine effectiveness, consider the immunological mechanisms that may be responsible for this connection, and explore the possibility of using gut microbiota-focused interventions to improve the efficacy of COVID-19 vaccines.
新型冠状病毒肺炎(COVID-19)疫苗在个体和人群之间的有效性存在差异,其原因仍不完全清楚。最近的临床研究和动物模型表明,肠道微生物群可能会影响疫苗的免疫原性,从而影响其有效性。这表明肠道微生物群和 COVID-19 疫苗之间存在双向关系,微生物群的不同成分可能增强或降低疫苗的效力。为了终结 COVID-19 大流行的传播,现在比以往任何时候都更需要能够产生强大和长期免疫力的疫苗,而了解肠道微生物群在这一过程中的作用至关重要。相反,COVID-19 疫苗也会对肠道微生物群产生重大影响,减少其总生物数量和存在的物种多样性。在这篇综述中,我们分析了表明肠道微生物群和 COVID-19 疫苗有效性之间存在相互作用的证据,考虑了可能导致这种联系的免疫机制,并探讨了使用以肠道微生物群为重点的干预措施来提高 COVID-19 疫苗效力的可能性。
World J Gastroenterol. 2022-10-28
Arch Toxicol. 2024-8
J Med Virol. 2022-4
Life Sci Alliance. 2024-2-5
Gut Microbes. 2025-12
MedComm (2020). 2024-3-15
J Health Popul Nutr. 2024-1-9
Front Microbiol. 2023-3-13
J Clin Invest. 2023-5-15